These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4066394)

  • 1. Reactivity of the serum from A-bomb survivors with the tissues of stomach, liver and kidney of normal rats.
    Yamakido M; Akiyama M; Takaishi M; Kobuke K; Fujiwara S; Hakoda M; Kyoizumi S; Kouno N; Yoshimoto K; Hamilton HB
    Hiroshima J Med Sci; 1985 Sep; 34(3):271-5. PubMed ID: 4066394
    [No Abstract]   [Full Text] [Related]  

  • 2. The gastric antibodies (intrinsic factor antibody and parietal cell antibody) and their clinical significances. (3). Thyroid disease, diabetes mellitus, iron deficiency anemia and atomic bomb survivors.
    Fujimura K
    Hiroshima J Med Sci; 1973 Sep; 22(2-3):265-97. PubMed ID: 4802622
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis associated antigen and antibody in A-bomb survivors and nonexposed subjects in Hiroshima and Nagasaki.
    Belsky JL; Okochi K; Ishimaru T; Hamilton HB
    Radiat Res; 1972 Dec; 52(3):528-35. PubMed ID: 4539561
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver function in survivors of the atomic bomb.
    Gregory PB; Amamoto K; Archer PG; Rickert RR; Omori Y; Bizzozero OJ; Hamilton HB; Johnson KG
    Radiat Res; 1975 Sep; 63(3):578-83. PubMed ID: 1162040
    [No Abstract]   [Full Text] [Related]  

  • 5. Testicular changes in atomic bomb survivors.
    Jordan SW; Hasegawa CM; Keehn RJ
    Arch Pathol; 1966 Dec; 82(6):542-54. PubMed ID: 5922670
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors.
    Hayashi T; Morishita Y; Kubo Y; Kusunoki Y; Hayashi I; Kasagi F; Hakoda M; Kyoizumi S; Nakachi K
    Am J Med; 2005 Jan; 118(1):83-6. PubMed ID: 15639214
    [No Abstract]   [Full Text] [Related]  

  • 7. A regression analysis on the mortality of the Hiroshima atomic bomb survivors.
    Watanabe M
    Hiroshima J Med Sci; 1970 Sep; 19(2):119-23. PubMed ID: 5512079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preleukemic state in atomic bomb survivors, with special reference to the relationship with aplastic anemia].
    Ichimaru M
    Rinsho Ketsueki; 1972 Jun; 13(3):335-7. PubMed ID: 4674963
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of gastric cancer in atomic bomb survivors residing in the Hiroshima area.
    Ito C; Hasegawa K; Kumasawa T
    Hiroshima J Med Sci; 1984 Mar; 33(1):47-52. PubMed ID: 6332801
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants.
    Kato H; Brown CC; Hoel DG; Schull WJ
    Radiat Res; 1982 Aug; 91(2):243-64. PubMed ID: 7100400
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of aplastic anemia in A-bomb survivors. Hiroshima and Nagasaki, 1946-1967.
    Ichimaru M; Ishimaru T; Tsuchimoto T; Kirshbaum JD
    Radiat Res; 1972 Feb; 49(2):461-72. PubMed ID: 5058082
    [No Abstract]   [Full Text] [Related]  

  • 12. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preleukemic state in atomic bomb survivors, with special reference to retro- and pro-spective analysis].
    Kamada N; Uchino H
    Rinsho Ketsueki; 1972 Jun; 13(3):313-22. PubMed ID: 4674959
    [No Abstract]   [Full Text] [Related]  

  • 14. Cataract in atomic bomb survivors.
    Minamoto A; Taniguchi H; Yoshitani N; Mukai S; Yokoyama T; Kumagami T; Tsuda Y; Mishima HK; Amemiya T; Nakashima E; Neriishi K; Hida A; Fujiwara S; Suzuki G; Akahoshi M
    Int J Radiat Biol; 2004 May; 80(5):339-45. PubMed ID: 15223766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spleen shielding in survivors of the atomic bomb.
    Gregory PB; Milton RC; Johnson ML; Taura T
    Radiat Res; 1968 Feb; 33(2):204-15. PubMed ID: 5637287
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation effects. U.S. could pull back on studies of atom bomb survivors.
    Malakoff D; Normile D
    Science; 2004 Apr; 304(5667):33. PubMed ID: 15060297
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of the mortality of A-bomb survivors. 4. Mortality and radiation dose, 1950-1966.
    Beebe GW; Kato H; Land CE
    Radiat Res; 1971 Dec; 48(3):613-49. PubMed ID: 5137468
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies and immunoglobulins among atomic bomb survivors.
    Fujiwara S; Carter RL; Akiyama M; Akahoshi M; Kodama K; Shimaoka K; Yamakido M
    Radiat Res; 1994 Jan; 137(1):89-95. PubMed ID: 8265792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bomb survivors and radiation protection.
    Lodico A
    Radiol Technol; 2009; 80(6):573-8. PubMed ID: 19584366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.